down arrow

Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,410.00
6.95 (0.5%)
BSENSE

Dec 05

BSE+NSE Vol: 42.1 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
10.46
10.46
10.46
9.51
9.51
Share Warrants & Outstandings
Total Reserve
1,802.26
1,516.18
1,279.54
1,093.71
760.72
Shareholder's Funds
1,812.72
1,526.65
1,290.00
1,103.22
770.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
6.24
31.25
35.53
Secured Loans
0.00
0.00
6.24
31.25
35.53
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
34.02
28.06
23.44
20.97
15.13
Other Long Term Liabilities
0.63
1.89
0.16
0.31
2.93
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.82
1.96
2.30
1.87
1.59
Total Non-Current Liabilities
37.47
31.91
32.13
54.40
55.19
Current Liabilities
Trade Payables
113.04
94.44
93.80
83.11
71.44
Other Current Liabilities
65.10
37.59
45.57
40.98
43.58
Short Term Borrowings
0.38
6.23
25.00
29.34
0.00
Short Term Provisions
5.54
3.90
27.48
1.75
0.28
Total Current Liabilities
184.06
142.16
191.84
155.17
115.31
Total Liabilities
2,034.25
1,700.71
1,513.98
1,312.79
940.73
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
1,093.13
822.25
791.43
717.48
306.96
Less: Accumulated Depreciation
300.73
250.20
198.71
145.87
70.55
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
792.40
572.05
592.72
571.61
236.41
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
50.13
211.48
172.70
74.16
141.40
Intangible assets under development
0.53
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
18.73
2.06
0.12
0.26
0.81
Long Term Loans & Advances
12.01
12.87
11.84
31.30
15.15
Other Non Current Assets
22.93
2.75
8.64
1.44
4.96
Total Non-Current Assets
899.01
804.48
786.28
680.13
401.93
Current Assets Loans & Advances
Current Investments
316.54
243.70
136.93
73.47
198.11
Inventories
239.67
207.95
212.31
195.12
111.23
Sundry Debtors
521.65
349.61
273.76
232.17
183.50
Cash and Bank
1.18
47.02
43.45
88.93
2.59
Other Current Assets
27.74
25.34
43.59
13.96
14.51
Short Term Loans and Advances
28.46
22.60
17.66
29.01
28.86
Total Current Assets
1,135.24
896.23
727.70
632.67
538.79
Net Current Assets (Including Current Investments)
951.18
754.08
535.86
477.50
423.49
Total Current Assets Excluding Current Investments
818.70
652.53
590.77
559.19
340.69
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
2,034.25
1,700.71
1,513.98
1,312.79
940.73
Contingent Liabilities
3.91
14.31
14.31
13.32
3.89
Total Debt
0.38
6.23
31.24
60.59
35.53
Book Value per share (adjusted)
173.27
145.93
123.31
105.453636363636
73.6245454545455
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -93.90% vs -80.06% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -66.67% vs 1,081.25% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 7.53% vs 2.37% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 809.22% vs 1,616.67% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 26.67% vs 23.16% in Mar 2024

Compare Balance Sheet Results of Concord Biotech
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.46
35.80
-25.34
-70.78%
Share Warrants & Outstandings
Total Reserve
1,802.26
7,571.20
-5,768.94
-76.20%
Shareholder's Funds
1,812.72
7,607.00
-5,794.28
-76.17%
Minority Interest
0.00
5.30
-5.30
-100.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
34.02
-49.90
83.92
168.18%
Other Long Term Liabilities
0.63
9.20
-8.57
-93.15%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.82
65.60
-62.78
-95.70%
Total Non-Current Liabilities
37.47
24.90
12.57
50.48%
Current Liabilities
Trade Payables
113.04
274.90
-161.86
-58.88%
Other Current Liabilities
65.10
317.60
-252.50
-79.50%
Short Term Borrowings
0.38
273.10
-272.72
-99.86%
Short Term Provisions
5.54
77.90
-72.36
-92.89%
Total Current Liabilities
184.06
943.50
-759.44
-80.49%
Total Liabilities
2,034.25
8,580.70
-6,546.45
-76.29%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,093.13
4,016.10
-2,922.97
-72.78%
Less: Accumulated Depreciation
300.73
1,268.10
-967.37
-76.28%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
792.40
2,698.00
-1,905.60
-70.63%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
50.13
225.40
-175.27
-77.76%
Intangible assets under development
0.53
0.00
0.53
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
18.73
152.80
-134.07
-87.74%
Long Term Loans & Advances
12.01
77.70
-65.69
-84.54%
Other Non Current Assets
22.93
156.80
-133.87
-85.38%
Total Non-Current Assets
899.01
3,310.70
-2,411.69
-72.85%
Current Assets Loans & Advances
Current Investments
316.54
320.80
-4.26
-1.33%
Inventories
239.67
765.80
-526.13
-68.70%
Sundry Debtors
521.65
1,246.60
-724.95
-58.15%
Cash and Bank
1.18
2,176.00
-2,174.82
-99.95%
Other Current Assets
27.74
135.10
-107.36
-79.47%
Short Term Loans and Advances
28.46
625.70
-597.24
-95.45%
Total Current Assets
1,135.24
5,270.00
-4,134.76
-78.46%
Net Current Assets (Including Current Investments)
951.18
4,326.50
-3,375.32
-78.02%
Total Current Assets Excluding Current Investments
818.70
4,949.20
-4,130.50
-83.46%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
2,034.25
8,580.70
-6,546.45
-76.29%
Contingent Liabilities
3.91
3.00
0.91
30.33%
Total Debt
0.38
273.10
-272.72
-99.86%
Book Value per share (adjusted)
173.27
424.97
-251.70
-59.23%
Annual - Borrowings
Borrowings 0.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -93.90% vs -80.06% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -66.67% vs 1,081.25% in Mar 2024

Annual - Fixed Assets
Fixed Assets 842.53 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.53% vs 2.37% in Mar 2024

Annual - Investments
Investments 18.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 809.22% vs 1,616.67% in Mar 2024

Annual - Current Assets
Current Assets 1,135.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.67% vs 23.16% in Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."